WhaleCreepWhat the best hedge funds own, from their SEC 13F filings
HomeStocks › RXRX

Which hedge funds own RXRX? RECURSION PHARMACEUTICALS IN, Q2 2026 13F holders

Healthcare · Open on the interactive board

7 of the hedge funds tracked by WhaleCreep disclosed a position in RXRX (RECURSION PHARMACEUTICALS IN) in their Q2 2026 13F filings, worth $131.1m in total. The largest holder by portfolio weight is Baillie Gifford at 0.1% of its book. 1 manager opened a new position this quarter: Bridgewater Associates. 2 exited: Brevan Howard Capital Management, Renaissance Technologies LLC.

7tracked managers holding
1opened this quarter
2exited this quarter

Which hedge funds hold RXRX? Current holders by portfolio weight

ManagerAs ofWeight of bookValueSharesΔ sharesAction
Baillie GiffordQ2 2026 0.1%$105.7m23,487,907 -1% reduced
Casdin CapitalQ2 2026 0.0%$606.7k165,323 0% held
Marshall WaceQ2 2026 0.0%$17.3m4,714,577 64% added
Millennium ManagementQ2 2026 0.0%$6.7m1,834,762 -30% reduced
Bridgewater AssociatesQ2 2026 0.0%$138.2k37,667 new
Citadel AdvisorsQ2 2026 0.0%$471.5k128,478 -79% reduced
D. E. Shaw & CoQ2 2026 0.0%$139.1k37,914 -18% reduced

Exited since the previous quarter

ManagerPrior weightPrior value
Brevan Howard Capital Management0.0%$409.3k
Renaissance Technologies LLC0.1%$7.4m

How has hedge fund ownership of RXRX changed?

QuarterManagers holdingCombined value
Q2 20267$131.1m
Q1 20269$46.9m
Q4 20253$28.6m
Q3 20252$35.3m
Q2 20252$38.1m
Q1 20252$76.4m
Q4 20244$60.8m
Q3 20244$163.2m
Q2 20244$261.4m
Q1 20243$105.4m
Q4 20235$127.3m
Q3 20236$97.6m
Q2 20234$107.1m
Q1 20234$142.8m
Q4 20224$32.9m
Q3 20224$108.3m

Counts every tracked manager that disclosed RXRX in that quarter's filing, including managers that have since stopped filing.